[The 5HT3-receptor antagonist Zofran (ondansetron) as an agent for preventing nausea and vomiting during the cytostatic treatment of cancer patients].
The authors describe regimens of Zofran application convenient in oncological practice to prevent nausea and vomiting in patients receiving cytostatic drugs. It is well tolerated and low toxic.